In addition, at both conferences, Vector BioMed will unveil an early look at the LENTIVERSE™, its boldest step yet toward a new era of lentiviral vector production. More than a platform ...

After countless hours of planning and building, it’s time to add the final ... See the list Bishop T.D. Jakes steps down from Dallas Megachurch Rock & Roll Hall of Fame 2025 inductees are ...

The global lentiviral vector CDMO market is set to witness a growth rate of 8% in the next 5 years. Growing demand for gene and cell therapies; expanding pipeline of gene therapy products; ...

The lentiviral vector market is rapidly growing, driven by advancements in gene therapy and increasing demand for innovative medical treatments. In 2023, the market was valued at USD 176.8 million and ...

Professor Amrolia selected ViroCell to manufacture the lentiviral vector for this novel CAR T-cell therapy based on its track record for delivering high quality vector. Through this relationship ...

AstraZeneca has entered the “off-the-shelf” cell therapy space, penning a $1 billion deal to acquire EsoBiotec and its lentiviral vector platform. The deal will see AstraZeneca scoop up all ...

This means that should everything go according to plan, the humanoid robot will eventually be put to work building itself ... The real-world validation is a key step toward scaling the robot ...

OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II trial of first-in-class gene therapy for cystic fibrosis Oxford, UK – 20 February 2025: ...

OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II trial of first-in-class gene therapy for cystic fibrosis Oxford, UK – 20 ...